Evidence map›Paper›PMID 27330289›Full record

ArticleInternational journal of nanomedicine2016

Duality of β-glucan microparticles: antigen carrier and immunostimulants.

Kim Baert, Bruno G De Geest, Henri De Greve, Eric Cox, Bert Devriendt

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Glucan and Mannan-Two Peas in a Pod.International journal of molecular sciences · 2019
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kim BaertDepartment of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Ghent, Belgium.
Bruno G De GeestDepartment of Pharmaceutics, Ghent University, Merelbeke, Ghent, Belgium.
Henri De GreveStructural Biology Research Centre, VIB, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.
Eric CoxDepartment of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Ghent, Belgium.
Bert DevriendtDepartment of Virology, Parasitology and Immunology, Ghent University, Merelbeke, Ghent, Belgium.
Ghent University · BEVIB-VUB Center for Structural Biology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designing efficient recombinant mucosal vaccines against enteric diseases is still a major challenge. Mucosal delivery of recombinant vaccines requires encapsulation in potent immunostimulatory particles to induce an efficient immune response. This paper evaluates the capacity of β-glucan microparticles (GPs) as antigen vehicles and characterizes their immune-stimulatory effects. The relevant infectious antigen FedF was chosen to be loaded inside the microparticles. The incorporation of FedF inside the particles was highly efficient (roughly 85%) and occurred without antigen degradation. In addition, these GPs have immunostimulatory effects as well, demonstrated by the strong reactive oxygen species (ROS) production by porcine neutrophils upon their recognition. Although antigen-loaded GPs still induce ROS production, antigen loading decreases this production by neutrophils for reasons yet unknown. However, these antigen-loaded GPs are still able to bind their specific β-glucan receptor, demonstrated by blocking complement receptor 3, which is the major β-glucan receptor on porcine neutrophils. The dual character of these particles is confirmed by a T-cell proliferation assay. FedF-loaded particles induce a significantly higher FedF-specific T-cell proliferation than soluble FedF. Taken together, these results show that GPs are efficient antigen carriers with immune-stimulatory properties.

Indexed as

Adhesins, BacterialAdjuvants, ImmunologicAnimalsAntigensbeta-GlucansCell ProliferationEscherichia coli ProteinsImmunomodulationProtein BindingProtein SubunitsReceptors, ComplementSus scrofaT-LymphocytesAdhesins, BacterialAdjuvants, ImmunologicAntigensbeta-GlucansEscherichia coli ProteinsFedF protein, E coliProtein SubunitsReceptors, Complementantigen delivery vehicleFedFimmunostimulantsβ-glucan microparticles

Identifiers

PMID27330289
PMCPMC4898424
OpenAlexW2417827508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.